NASDAQ:IMV
Delisted
IMV Inc. Stock News
$0.82
+0 (+0%)
At Close: Jul 27, 2023
IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020
11:05am, Monday, 03'rd Aug 2020
IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020
IMV to Present at BTIG’s Virtual Biotechnology Conference
11:05am, Wednesday, 29'th Jul 2020
IMV to Present at BTIG’s Virtual Biotechnology Conference
IMV Inc. (IMV) Shares March Higher, Can It Continue?
02:20pm, Thursday, 23'rd Jul 2020
As of late, it has definitely been a great time to be an investor in IMV Inc. (IMV).
How Does IMV's (TSE:IMV) CEO Pay Compare With Company Performance?
07:35pm, Monday, 20'th Jul 2020
Fred Ors has been the CEO of IMV Inc. (TSE:IMV) since 2016, and this article will examine the executive's compensation...
IMV Announces Appointment of Michael P. Bailey to Board of Directors
11:05am, Monday, 20'th Jul 2020
IMV Announces Appointment of Michael P. Bailey to Board of Directors
IMV Catches Eye: Stock Jumps 10%
12:51pm, Friday, 17'th Jul 2020
IMV saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
Canadian Biotech IMV 'Rapidly' Progressing On Coronavirus Vaccine Development
03:07pm, Tuesday, 14'th Jul 2020
Imv Inc (NASDAQ: IMV) share are ripping higher on above-average volume following an update by the company on its coronavirus vaccine program.What Happened? The Dartmouth, Nova Scotia-based company sai
IMV Pops 134% In Pre-Market On “Rapid Progress” Of Covid-19 Vaccine Development
01:01pm, Tuesday, 14'th Jul 2020
Shares in IMV Inc. (IMV) are spiking 134% in Tuesday’s pre-market trading after the clinical-stage biopharma company said it made “rapid progress” in developing its candidate vaccine to prevent
IMV Updates Rapid Progress on COVID-19 Vaccine Program
11:05am, Tuesday, 14'th Jul 2020
IMV Updates Rapid Progress on COVID-19 Vaccine Program
IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus
09:05pm, Tuesday, 30'th Jun 2020
IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus
IMV Announces Annual and Special Meeting of Shareholders Voting Results
09:05pm, Monday, 29'th Jun 2020
IMV announces Annual and Special Meeting of Shareholders voting results
IMV Files Preliminary Base Shelf Prospectus to Replace Expiring Base Shelf Prospectus
08:26pm, Friday, 19'th Jun 2020
IMV Inc. ("IMV" or the "Company") (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of targeted cancer immunotherapies and vaccines against infectious diseas
IMV Announces Leading Independent Proxy Advisory Firms Recommend Shareholders Vote FOR All Resolutions at Upcoming Annual and Special Meeting
IMV to Present at Raymond James' Human Health Innovation Conference
11:05am, Monday, 08'th Jun 2020
IMV to Present at Raymond James' Human Health Innovation Conference
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of targeted cancer immunotherapies and vaccines against infectious diseases, today reported update
